6926.TWO
Price:
$63.3
Market Cap:
$3.15B
Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2021 and is based in Taichung, Taiwan.
Industry
Biotechnology
IPO Date
2022-11-25
Stock Exchange
TWO
Ticker
6926.TWO
According to Shine-On BioMedical Co.,Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -26.49. This represents a change of -18.06% compared to the average of -32.33 of the last 4 quarters.
The mean historical PE Ratio of Shine-On BioMedical Co.,Ltd. over the last ten years is -70.97. The current -26.49 PE Ratio has changed 3.63% with respect to the historical average. Over the past ten years (40 quarters), 6926.TWO's PE Ratio was at its highest in in the June 2020 quarter at 0. The PE Ratio was at its lowest in in the June 2021 quarter at -81.63.
Average
-70.97
Median
-58.55
Minimum
-163.26
Maximum
0
Discovering the peaks and valleys of Shine-On BioMedical Co.,Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = 0%
Minimum Annual PE Ratio = -163.26
Year | PE Ratio | Change |
---|---|---|
2024 | -28.52 | -67.79% |
2023 | -88.57 | -39.10% |
2022 | -145.45 | -10.91% |
2021 | -163.26 | -Infinity% |
2020 | 0 | 0% |
The current PE Ratio of Shine-On BioMedical Co.,Ltd. (6926.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-87.52
5-year avg
-85.16
10-year avg
-70.97
Shine-On BioMedical Co.,Ltd.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shine-On BioMedical Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Shine-On BioMedical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Shine-On BioMedical Co.,Ltd.'s PE Ratio?
How is the PE Ratio calculated for Shine-On BioMedical Co.,Ltd. (6926.TWO)?
What is the highest PE Ratio for Shine-On BioMedical Co.,Ltd. (6926.TWO)?
What is the 3-year average PE Ratio for Shine-On BioMedical Co.,Ltd. (6926.TWO)?
What is the 5-year average PE Ratio for Shine-On BioMedical Co.,Ltd. (6926.TWO)?
How does the current PE Ratio for Shine-On BioMedical Co.,Ltd. (6926.TWO) compare to its historical average?